Stephanie Gasking
Clinical Oncology Society of Australia Annual Scientific Meeting 2024
Days
Tuesday, 12th November
Wednesday, 13th November
Thursday, 14th November
Friday, 15th November
Search
Speakers
Stephanie Gasking
Abstracts this author is presenting:
Health-related quality of life (HRQoL) with tepotinib in patients with
MET
exon 14 (
MET
ex14) skipping non-small cell lung cancer (NSCLC) with brain, liver, adrenal or bone metastases in the Phase II VISION trial
—
Afternoon Tea, Exhibition & Poster Session 1
AUSTRALI-AVE: design of a retrospective noninterventional study evaluating real-world patient characteristics and treatment patterns with avelumab in locally advanced or metastatic urothelial cancer (la/mUC) and metastatic Merkel cell carcinoma (mMCC) in Australia
—
Afternoon Tea, Exhibition & Poster Session 2